The aortic stent grafts market has seen considerable growth due to a variety of factors.
• The aortic stent grafts market has experienced strong growth in recent years. It is expected to rise from $3.32 billion in 2024 to $3.61 billion in 2025, at a compound annual growth rate (CAGR) of 8.8%.
This growth can be attributed to the shift toward minimally invasive surgeries, longer life expectancy, greater use of diagnostic imaging technologies, advancements in medical science, and the increased adoption of endovascular repair techniques.
The aortic stent grafts market is expected to maintain its strong growth trajectory in upcoming years.
• The aortic stent grafts market is expected to grow rapidly, reaching $5.02 billion by 2029 at a CAGR of 8.6%.
Factors contributing to this growth include improved healthcare infrastructure, favorable reimbursement policies, a shift towards bifurcated abdominal aortic stent grafts, the rise of hybrid procedures, and a greater focus on training for healthcare professionals. Major trends include technological innovations, new product development, increased regulatory approvals, more research and development investments, and improved healthcare infrastructure.
Gain Insights Into The Aortic Stent Grafts Global Market Report 2025 With A Free Sample Report Here:
The rise in cardiovascular diseases is expected to drive the growth of the aortic stent graft market. Cardiovascular diseases, often linked to lifestyle factors such as poor diet, smoking, and obesity, are on the rise globally. Aortic stent grafts are used to repair weakened or damaged sections of the aorta, particularly in cases of aneurysms. In 2024, the British Heart Foundation reported that coronary heart disease was responsible for around 68,000 deaths annually in the UK, underscoring the need for aortic stent grafts.
The aortic stent grafts market covered in this report is segmented –
1) By Product: Abdominal Aortic Stents Graft, Thoracic Aortic Stents Graft
2) By Type: Abdominal Aortic Aneurysms, Thoracic Aortic Aneurysms
3) By End User: Hospitals, Ambulatory Surgical Centers Or Outpatient Surgical Centers, Other End-Users
Subsegments:
1) By Abdominal Aortic Stent Graft: Endovascular Aneurysm Repair (EVAR) Stent Grafts, Aortic Aneurysm Stent Grafts
2) By Thoracic Aortic Stent Graft: Thoracic Endovascular Aortic Repair (TEVAR) Stent Grafts, Hybrid Aortic Stent Grafts
Companies in the aortic stent graft market are concentrating on developing advanced stent-graft systems that offer improved stability, flexibility, and lower complication risks. A stent-graft system is used in endovascular procedures to treat aneurysms and consists of a stent for support and a graft to reinforce the vessel wall. In August 2024, Terumo India, an India-based medical device company, launched the TREO Abdominal Stent-Graft system, which is designed to treat infrarenal abdominal aortic aneurysms with enhanced sealing, adjustability, and robust fixation for better long-term patient outcomes.
Major companies operating in the aortic stent grafts market are:
• Cardinal Health Inc.
• Medtronic plc
• Aptus Endosystems Inc.
• B. Braun Inc.
• Terumo Corporation
• W.L. Gore & Associates Inc.
• Cook Medical Inc.
• Getinge AB
• Merit Medical Systems Inc.
• MicroPort Scientific Corporation
• Seisa Medical Inc.
• Artivion Inc.
• Lifetech Scientific (Shenzhen) Co. Ltd.
• Endologix Inc.
• Braile Biomédica
• Biomerics LLC
• Jotech GmbH
• OptiMed Medizinische Instrumente GmbH
• Bentley InnoMed GmbH
• Endospan Ltd.
North America was the largest region in the aortic stent grafts market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the aortic stent grafts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.